Health Catalyst Inc (HCAT)
8.31
-0.08
(-0.95%)
USD |
NASDAQ |
Sep 27, 16:00
8.34
+0.03
(+0.36%)
After-Hours: 20:00
Health Catalyst SG&A Expense (TTM): 122.14M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 122.14M |
March 31, 2024 | 135.10M |
December 31, 2023 | 143.88M |
September 30, 2023 | 147.70M |
June 30, 2023 | 163.59M |
March 31, 2023 | 161.98M |
December 31, 2022 | 149.22M |
September 30, 2022 | 159.89M |
June 30, 2022 | 159.16M |
March 31, 2022 | 159.94M |
December 31, 2021 | 160.96M |
September 30, 2021 | 156.68M |
Date | Value |
---|---|
June 30, 2021 | 140.74M |
March 31, 2021 | 122.13M |
December 31, 2020 | 114.65M |
September 30, 2020 | 91.81M |
June 30, 2020 | 89.62M |
March 31, 2020 | 85.54M |
December 31, 2019 | 79.00M |
September 30, 2019 | 76.48M |
June 30, 2019 | 70.12M |
March 31, 2019 | 72.84M |
December 31, 2018 | 66.81M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
76.48M
Minimum
Sep 2019
163.59M
Maximum
Jun 2023
131.01M
Average
142.31M
Median
SG&A Expense (TTM) Benchmarks
Regional Health Properties Inc | 4.619M |
Amedisys Inc | 781.75M |
Addus HomeCare Corp | 245.68M |
OptimizeRx Corp | 62.29M |
Option Care Health Inc | 614.52M |